U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180091180091Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune ResponseCompletedNo Results AvailableHepatitis BBiological: Hepatitis B vaccinehttps://ClinicalTrials.gov/show/NCT00197158
180092180092Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNo Results AvailableHIV InfectionDrug: GW873140https://ClinicalTrials.gov/show/NCT00197145
180093180093Study In Patients With Insulin ResistanceCompletedNo Results AvailableInsulin ResistanceDrug: Avandiahttps://ClinicalTrials.gov/show/NCT00197132
180094180094Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 YearsCompletedHas ResultsHepatitis B|Hepatitis ABiological: Twinrixâ„¢ Adult|Biological: Twinrixâ„¢ Juniorhttps://ClinicalTrials.gov/show/NCT00197119
180095180095Treatment Of Symptomatic Asthma In ChildrenCompletedHas ResultsAsthmaDrug: Salmeterol/ fluticasone propionate Diskus® inhaler 50/100 mcg|Drug: fluticasone propionate 2 x 100 mcghttps://ClinicalTrials.gov/show/NCT00197106
180096180096In-Patient Study In Schizophrenic PatientsCompletedNo Results AvailableSchizophreniaDrug: SB773812https://ClinicalTrials.gov/show/NCT00197093
180097180097Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedNo Results AvailableRestless Legs Syndrome|Restless Legs Syndrome (RLS)Drug: Ropinirole Extended Release (XR)https://ClinicalTrials.gov/show/NCT00197080
180098180098A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a MCompletedNo Results AvailableMalariaBiological: RTS,S/AS02D and RTS,S/AS02Ahttps://ClinicalTrials.gov/show/NCT00197067
180099180099A Study to Evaluate Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02A, and RTS,S/AS01B, Two Candidate Malaria Vaccines in Malaria-experienced Adults Living in Western Kenya.CompletedNo Results AvailablePlasmodium FalciparumBiological: RTS,S/AS02A and RTS,S/AS01Bhttps://ClinicalTrials.gov/show/NCT00197054
180100180100A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.CompletedNo Results AvailableMalariaBiological: RTS,S/AS02Ahttps://ClinicalTrials.gov/show/NCT00197041
180101180101Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic RegionCompletedHas ResultsMalariaBiological: RTS,S/AS02D|Biological: TETRActHib™|Biological: Engerix-B®https://ClinicalTrials.gov/show/NCT00197028
180102180102Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedHas ResultsHepatitis ABiological: Havrix®|Biological: M-M-R®II|Biological: VARIVAX®https://ClinicalTrials.gov/show/NCT00197015
180103180103Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of AgeCompletedNo Results AvailableHepatitis ABiological: Hepatitis Ahttps://ClinicalTrials.gov/show/NCT00197002
180104180104Study In People With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Pioglitazone|Drug: GW677954https://ClinicalTrials.gov/show/NCT00196989
180105180105Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years OldCompletedNo Results AvailableInfections, MeningococcalBiological: Conjugated meningococcal ACWY-TT (vaccine)|Biological: DTPa-IPV/Hib vaccine (Infanrixâ„¢-IPV/Hib)|Biological: DTPa-HBV-IPV/Hib vaccine (Infanrix hexaâ„¢)|Biological: Meningitecâ„¢|Biological: Mencevaxâ„¢ACWYhttps://ClinicalTrials.gov/show/NCT00196976
180106180106Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 YrsCompletedNo Results AvailableMeningococcal Serogroup DiseasesBiological: Meningococcal (vaccine)https://ClinicalTrials.gov/show/NCT00196963
180107180107Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 YearsCompletedNo Results AvailableMeningococcal Serogroup DiseasesBiological: Meningococcal (vaccine)https://ClinicalTrials.gov/show/NCT00196950
180108180108Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18CompletedHas ResultsInfections, PapillomavirusBiological: Cervarixâ„¢https://ClinicalTrials.gov/show/NCT00196937
180109180109Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.CompletedNo Results AvailableHuman Papillomavirus (HPV) Infection|Cervical NeoplasiaBiological: HPV-16/18 L1/AS04https://ClinicalTrials.gov/show/NCT00196924
180110180110STN-Stimulation Versus Best Medical Treatment in Advanced PDCompletedNo Results AvailableParkinson's DiseaseProcedure: Implantation of stimulation electrodes in the STNhttps://ClinicalTrials.gov/show/NCT00196911
180111180111Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine AgonistsRecruitingNo Results AvailableHeart Valve Diseases|Parkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00196898
180112180112Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise TrainingCompletedNo Results AvailableGastrointestinal Neoplasms|Bronchial Carcinoma|Hodgkin Disease|Non-Hodgkin Lymphoma|Weight LossDrug: N-acetylcysteinehttps://ClinicalTrials.gov/show/NCT00196885
180113180113A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)CompletedNo Results AvailableBreast CancerDrug: Epirubicine|Drug: Cyclophosphamide|Drug: Taxol|Drug: Xeloda|Drug: Ibandronathttps://ClinicalTrials.gov/show/NCT00196872
180114180114Study in Elderly Patients With Early Breast Cancer (ICE)CompletedNo Results AvailableBreast CancerDrug: Ibandronate, Capecitabine|Drug: Ibandronatehttps://ClinicalTrials.gov/show/NCT00196859
180115180115Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)CompletedNo Results AvailableBreast CancerDrug: Goserelinhttps://ClinicalTrials.gov/show/NCT00196846
180116180116Breast Cancer in PregnancyRecruitingNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00196833
180117180117Mono Efficacy of Capecitabine (MoniCa)CompletedNo Results AvailableBreast CancerDrug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00196820
180118180118Prostate Cancer Screening: Fostering Informed DecisionsCompletedNo Results AvailableProstate CancerBehavioral: patient decision aid (print-based)https://ClinicalTrials.gov/show/NCT00196807
180119180119A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCompletedNo Results AvailableClostridium Enterocolitis|DiarrheaDrug: Tolevamer potassium-sodium (GT267-004)https://ClinicalTrials.gov/show/NCT00196794
180120180120Treatment Decision Making in Early-Stage Prostate CancerCompletedNo Results AvailableLocalized Prostate CancerBehavioral: CD-ROM-based prostate cancer treatment education|Behavioral: CD-ROM-based prostate ca treatment education+decision toolshttps://ClinicalTrials.gov/show/NCT00196781

* Görseller ve İçerik tekif hakkına sahip olabilir